Lyell Immunopharma
LYEL
LYEL
119 hedge funds and large institutions have $194M invested in Lyell Immunopharma in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 45 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 45
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
35% less capital invested
Capital invested by funds: $297M → $194M (-$103M)
Holders
119
Holding in Top 10
4
Calls
$17K
Puts
$14K
Top Buyers
| 1 | +$9M | |
| 2 | +$1.65M | |
| 3 | +$1.09M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$763K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$533K |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$1.94M | |
| 3 | -$1.78M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$1.4M |
| 5 |
JPMorgan Chase & Co
New York
|
-$808K |